Drugs & Targets Enfortumab vedotin gets FDA accelerated approval for advanced urothelial or bladder cancer January 10, 2020Vol.46 No.02
Drugs & Targets FDA grants IceCure clearance for expanded indications of cryoablation technology and regulatory approval of MultiSense system January 10, 2020Vol.46 No.02
Drugs & Targets Canada approves treatment for relapsed/refractory chronic lymphocytic leukemia as part of Project Orbis collaboration January 10, 2020Vol.46 No.02
Clinical Roundup Keytruda shows mixed results in late-stage lung cancer study January 10, 2020Vol.46 No.02
Clinical Roundup Breast density notification laws not effective for all women January 10, 2020Vol.46 No.02
Clinical Roundup Researchers surprised by high levels of alcohol consumption among cancer survivors January 10, 2020Vol.46 No.02
Clinical Roundup Surgery may add months or years of survival for adults with high-grade gliomas January 10, 2020Vol.46 No.02
Trials & Tribulations Advancing the science of cancer in Latinos January 10, 2020Vol.46 No.02By Amelie G. Ramirez and Ruben A. Mesa
Funding Opportunities ALK Positive and LUNGevity issue RFA for 2020 ALK-positive Lung Cancer Research Award Program January 10, 2020Vol.46 No.02
